Business Context and Reporting Period
Company: Medifast, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Business Overview: Medifast produces, distributes, and sells weight management and disease management products, primarily meal replacements and vitamins. Operations are conducted through five wholly-owned subsidiaries. The company utilizes a multi-channel distribution strategy including direct-to-consumer (Medifast Direct), a physician-led network (Take Shape for Life), physician sales, and corporately owned weight control centers.
Key Financial Metrics
| Metric | 2007 | 2006 |
|---|---|---|
| Revenue | $83,779,000 | $74,086,000 |
| Gross Profit | $62,315,000 | $55,849,000 |
| Gross Margin | 74.4% | 75.4% |
| Operating Income | $5,715,000 | $7,381,000 |
| Net Income | $3,837,000 | $5,156,000 |
| Diluted EPS | $0.28 | $0.38 |
| Cash from Operations | $7,954,000 | $5,845,000 |
| Total Assets | $43,724,000 | $36,677,000 |
| Total Debt (Long-term + Current) | $6,433,000 | $5,313,000 |
| Working Capital | $10,395,000 | $9,612,000 |
| Cash and Equivalents | $2,195,000 | $1,085,000 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 13% year-over-year to $83.8 million. Growth was driven by the Take Shape for Life division (+23%) and Medifast Weight Control Centers (+37%), while the direct marketing channel grew modestly (+3%).
- Profitability Decline: Despite revenue growth, Net Income decreased 26% to $3.8 million. This was primarily due to a $4.1 million increase in advertising expenses ($18.4M in 2007 vs. $14.3M in 2006) and increased salaries/benefits to support infrastructure expansion.
- Segment Performance: The core "Medifast" segment remained profitable ($5.9M), while the "All Other" segment (including clinics and corporate expenses) reported a loss of $2.1M, an increase in loss from the prior year due to investments in clinic expansion and franchise development.
- Debt Refinancing: In September 2007, the company increased its secured line of credit from $5 million to $7.5 million and refinanced existing term loans with Merrill Lynch.
Guidance, Outlook, and Risks
Outlook and Strategy:
- Expansion: Management plans to open four additional corporately owned clinics in Houston, TX, by Q1 2008 and has sold its first franchise for the Baltimore area.
- Marketing: Significant investment in celebrity endorsements and brand awareness campaigns is expected to continue, with a focus on improving advertising effectiveness.
- Infrastructure: The company has invested heavily in IT systems (ERP), manufacturing capacity, and call center infrastructure to handle sales volumes up to $250-$300 million.
Risks and Contingencies:
- Advertising Dependency: Future profitability is heavily dependent on the effectiveness of advertising spend in the direct-to-consumer channel.
- Competition: Risks from new fad diets, pharmaceutical weight loss solutions, and larger competitors with more resources.
- Regulatory: Operations are subject to FDA, FTC, and state regulations regarding product labeling, advertising claims, and direct selling practices.
- Legal Proceedings: An ongoing lawsuit (Sotomeyer v. Medifast) regarding consulting agreements remains in discovery; management believes it has a meritorious defense and expects no material impact.
Investor Verification Checklist
- Advertising ROI: Verify the correlation between the increased $18.4M advertising spend and customer acquisition costs to ensure future profitability.
- Clinic Economics: Review the unit economics of the new Medifast Weight Control Centers and the success of the first franchise sale in Baltimore.
- Debt Service: Confirm the company's ability to service $6.4M in debt, noting that nearly all debt is variable-rate (LIBOR + spread), exposing the company to interest rate risk.
- Inventory Levels: Monitor inventory levels ($9.2M), which increased significantly in Q4 2007 in preparation for the "diet season" in Q1 2008.
- Executive Retention: Note the recent modification of the Executive Chairman's compensation package (options replaced with restricted stock) and the reliance on key management under long-term employment agreements.